市場調查報告書

全球癌症疫苗市場規模調查:各類型,各技術,各適應症,各終端用戶,及各地區預測:2020∼2027年

Global Cancer Vaccines Market Size study, by Type, by Technology, by Indication, by End-User and Regional Forecasts 2020-2027

出版商 Bizwit Research & Consulting LLP 商品編碼 956201
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球癌症疫苗市場規模調查:各類型,各技術,各適應症,各終端用戶,及各地區預測:2020∼2027年 Global Cancer Vaccines Market Size study, by Type, by Technology, by Indication, by End-User and Regional Forecasts 2020-2027
出版日期: 2020年08月28日內容資訊: 英文
簡介

全球癌症疫苗的市場規模2019年價值約42億美元,在2020∼2027年預測期間預計將以超越12.6%的健全的成長率成長。

癌症患者數的增加,對癌症治療的患者的意識的高漲,及癌症疫苗的開發的投資和政府資金的增加,成為在預測期間內市場年複合成長率的要素。世界的癌症的罹患趨勢,預計至2040年,新病例數約達2,750萬件,因癌症的死亡人數增加到近1,630萬人。全球將提高對癌症疫苗的需求。但,疫苗的開發成本高,有關產品認證的嚴格政府的規範和政策,成為從2020年到2027年的預測期間妨礙市場成長的要素。

本報告提供全球癌症疫苗市場相關調查,市場概要,以及各類型,各技術,各適應症,各終端用戶,各地區的趨勢,及加入此市場的主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 全球癌症疫苗市場定義和範圍

第3章 全球癌症疫苗市場動態

  • 癌症疫苗市場影響分析(2018-2027)

第4章 全球癌症疫苗市場:產業分析

  • 波特五力模式
  • PEST分析
  • 投資採用模式
  • 分析師的建議與結論

第5章 各類型全球癌症疫苗市場

  • 市場概述
  • 各類型全球癌症疫苗市場,效能-潛力分析
  • 各類型全球癌症疫苗市場預算與預測:2017-2027年(10億美元)
  • 癌症疫苗市場,子區隔分析
    • 預防用癌症疫苗
    • 治療用癌症疫苗

第6章 各技術全球癌症疫苗市場

  • 市場概述
  • 各技術全球癌症疫苗市場,效能-潛力分析
  • 各技術全球癌症疫苗市場預算與預測:2017-2027年(10億美元)
  • 癌症疫苗市場,子區隔分析
    • 樹突狀細胞(DC)癌症疫苗
    • 重組癌症疫苗
    • 抗原/佐劑癌症疫苗
    • 病毒載體及DNA癌症疫苗

第7章 各適應症全球癌症疫苗市場

  • 市場概述
  • 各適應症全球癌症疫苗市場,效能-潛力分析
  • 各適應症全球癌症疫苗市場預算與預測:2017-2027年(10億美元)
  • 癌症疫苗市場,子區隔分析
    • 子宮頸癌
    • 前列腺癌
    • 其他

第8章 各終端用戶全球癌症疫苗市場

  • 市場概述
  • 各終端用戶全球癌症疫苗市場,效能-潛力分析
  • 各終端用戶全球癌症疫苗市場預算與預測:2017-2027年(10億美元)
  • 癌症疫苗市場,子區隔分析
    • 兒童
    • 成人

第9章 全球癌症疫苗市場,地區分析

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲的概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區的概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他
  • 南美的概述
    • 巴西
    • 墨西哥
  • 其他

第10章 競爭資訊

  • 最高市場策略
  • 企業簡介
    • Advaxis Inc.
    • Amgen Inc.
    • Dynavax Technologies Corporation
    • Generex Biotechnology Corporation
    • GlaxoSmithKline plc (GSK)
    • Immunocellular Therapeutics, Ltd.
    • Merck & Co., Inc.
    • Sanpower Group Co. Ltd.
    • UbiVac, Inc.
    • Vaccinogen, Inc.

第11章 調查流程

目錄

Title:
Global Cancer Vaccines Market Size study, by Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), by Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), by Indication (Cervical Cancer, Prostate Cancer, Others), by End-User (Pediatrics, Adults) and Regional Forecasts 2020-2027.

Global Cancer Vaccines Market is valued at approximately USD 4.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.6% over the forecast period 2020-2027. Cancer vaccines are a form of immunotherapy which is considered as a biological response modifier. Usually, cancer treatment vaccines are distinct from the vaccines that work against bacteria and viruses. Cancer vaccines can stimulate the immune system of the patient's body to fight against cancer cells. Rather than preventing disease, these vaccines are primarily focused to boost the immune systems to medicate a disease that already occurred in the patient's body. The cancer vaccines are generally available in two types i.e. preventive cancer vaccines and therapeutic cancer vaccines. Preventive cancer vaccines are typically used to prevent cancer disease among healthy people, whereas therapeutic cancer vaccines are used to strengthen the immune response among patients to fight against the disease. An increase in the number of cancer patients, growing awareness among patients towards cancer therapy, and rising investment and government funding in the development of cancer vaccine are the few factors responsible for the CAGR of the market during the forecast period. According to the International Agency for Research on Cancer (IARC), around 18.1 million new cancer cases and 9.6 million cancer deaths were reported throughout the world in 2018. Also, the global prevalence of cancer is projected to grow to around 27.5 million new cancer cases and nearly 16.3 million cancer deaths by the year 2040. This, in turn, is likely to strengthen the demand for Cancer Vaccines, globally. However, the high development cost of vaccine and stringent government norms & policies on product approval are the few factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global Cancer Vaccines market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the favorable government support for the approval of cancer vaccines, along with the wide presence of market players in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of cancer and improving healthcare infrastructure in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the cancer vaccine market in the Asia-Pacific region.

Major market player included in this report are:

Advaxis Inc.

Amgen Inc.

Dynavax Technologies Corporation

Generex Biotechnology Corporation

GlaxoSmithKline plc (GSK)

Immunocellular Therapeutics, Ltd.

Merck & Co., Inc.

Sanpower Group Co. Ltd.

UbiVac, Inc.

Vaccinogen, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Preventive Cancer Vaccines

Therapeutic Cancer Vaccines

By Technology:

Dendritic Cells (DC) Cancer Vaccines

Recombinant Cancer Vaccines

Antigen/Adjuvant Cancer Vaccines

Viral Vector & DNA Cancer Vaccines

By Indication:

Cervical Cancer

Prostate Cancer

Others

By End-User:

Pediatrics

Adults

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Cancer Vaccines Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Cancer Vaccines Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Cancer Vaccines Market, by Type, 2018-2027 (USD Billion)
    • 1.2.3. Cancer Vaccines Market, by Technology, 2018-2027 (USD Billion)
    • 1.2.4. Cancer Vaccines Market, by Indication, 2018-2027 (USD Billion)
    • 1.2.5. Cancer Vaccines Market, by End-User, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cancer Vaccines Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cancer Vaccines Market Dynamics

  • 3.1. Cancer Vaccines Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Cancer Vaccines Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Cancer Vaccines Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Cancer Vaccines Market by Type, Performance - Potential Analysis
  • 5.3. Global Cancer Vaccines Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
  • 5.4. Cancer Vaccines Market, Sub Segment Analysis
    • 5.4.1. Preventive Cancer Vaccines
    • 5.4.2. Therapeutic Cancer Vaccines

Chapter 6. Global Cancer Vaccines Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Cancer Vaccines Market by Technology, Performance - Potential Analysis
  • 6.3. Global Cancer Vaccines Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
  • 6.4. Cancer Vaccines Market, Sub Segment Analysis
    • 6.4.1. Dendritic Cells (DC) Cancer Vaccines
    • 6.4.2. Recombinant Cancer Vaccines
    • 6.4.3. Antigen/Adjuvant Cancer Vaccines
    • 6.4.4. Viral Vector & DNA Cancer Vaccines

Chapter 7. Global Cancer Vaccines Market, by Indication

  • 7.1. Market Snapshot
  • 7.2. Global Cancer Vaccines Market by Indication, Performance - Potential Analysis
  • 7.3. Global Cancer Vaccines Market Estimates & Forecasts by Indication 2017-2027 (USD Billion)
  • 7.4. Cancer Vaccines Market, Sub Segment Analysis
    • 7.4.1. Cervical Cancer
    • 7.4.2. Prostate Cancer
    • 7.4.3. Others

Chapter 8. Global Cancer Vaccines Market, by End-User

  • 8.1. Market Snapshot
  • 8.2. Global Cancer Vaccines Market by End-User - Potential Analysis
  • 8.3. Global Cancer Vaccines Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
  • 8.4. Cancer Vaccines Market, Sub Segment Analysis
    • 8.4.1. Paediatrics
    • 8.4.2. Adults

Chapter 9. Global Cancer Vaccines Market, Regional Analysis

  • 9.1. Cancer Vaccines Market, Regional Market Snapshot
  • 9.2. North America Cancer Vaccines Market
    • 9.2.1. U.S. Cancer Vaccines Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2017-2027
      • 9.2.1.2. Technology breakdown estimates & forecasts, 2017-2027
      • 9.2.1.3. Indication breakdown estimates & forecasts, 2017-2027
      • 9.2.1.4. End-User breakdown estimates & forecasts, 2017-2027
    • 9.2.2. Canada Cancer Vaccines Market
  • 9.3. Europe Cancer Vaccines Market Snapshot
    • 9.3.1. U.K. Cancer Vaccines Market
    • 9.3.2. Germany Cancer Vaccines Market
    • 9.3.3. France Cancer Vaccines Market
    • 9.3.4. Spain Cancer Vaccines Market
    • 9.3.5. Italy Cancer Vaccines Market
    • 9.3.6. Rest of Europe Cancer Vaccines Market
  • 9.4. Asia-Pacific Cancer Vaccines Market Snapshot
    • 9.4.1. China Cancer Vaccines Market
    • 9.4.2. India Cancer Vaccines Market
    • 9.4.3. Japan Cancer Vaccines Market
    • 9.4.4. Australia Cancer Vaccines Market
    • 9.4.5. South Korea Cancer Vaccines Market
    • 9.4.6. Rest of Asia Pacific Cancer Vaccines Market
  • 9.5. Latin America Cancer Vaccines Market Snapshot
    • 9.5.1. Brazil Cancer Vaccines Market
    • 9.5.2. Mexico Cancer Vaccines Market
  • 9.6. Rest of The World Cancer Vaccines Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Advaxis Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Amgen Inc.
    • 10.2.3. Dynavax Technologies Corporation
    • 10.2.4. Generex Biotechnology Corporation
    • 10.2.5. GlaxoSmithKline plc (GSK)
    • 10.2.6. Immunocellular Therapeutics, Ltd.
    • 10.2.7. Merck & Co., Inc.
    • 10.2.8. Sanpower Group Co. Ltd.
    • 10.2.9. UbiVac, Inc.
    • 10.2.10. Vaccinogen, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF FIGURES

  • FIG 1. Global Cancer Vaccines market, research methodology
  • FIG 2. Global Cancer Vaccines market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Cancer Vaccines market, key trends 2019
  • FIG 5. Global Cancer Vaccines market, growth prospects 2020-2027
  • FIG 6. Global Cancer Vaccines market, porters 5 force model
  • FIG 7. Global Cancer Vaccines market, pest analysis
  • FIG 8. Global Cancer Vaccines market, value chain analysis
  • FIG 9. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
  • FIG 10. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
  • FIG 11. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
  • FIG 12. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
  • FIG 13. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
  • FIG 14. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
  • FIG 15. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
  • FIG 16. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
  • FIG 17. Global Cancer Vaccines market, regional snapshot 2017 & 2027
  • FIG 18. North America Cancer Vaccines market 2017 & 2027 (USD Billion)
  • FIG 19. Europe Cancer Vaccines market 2017 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Cancer Vaccines market 2017 & 2027 (USD Billion)
  • FIG 21. Latin America Cancer Vaccines market 2017 & 2027 (USD Billion)
  • FIG 22. Global Cancer Vaccines market, company market share analysis (2019)